Cell line · CVCL_0358
Papers34
3 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
1 to 20 of 34
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Transcription Factor Rv1453 Contributes to Multidrug Sensitivity of Mycobacterium tuberculosis: A Potential Role for Lipid Metabolism. | Microorganisms | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Reassessment of the roles of coronin proteins as actin effectors and in signaling. | PLoS Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Investigating the role of baseline gut Akkermansia muciniphila and its co-metabolite palmitoleic acid in BCG vaccine efficacy: a preclinical study. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Immunomodulatory Potential of Quinoline Q3, a Selective Inhibitor of the Canonical NF-κB Pathway in Macrophages. | ChemMedChem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Oral Delivery of Mesenchymal Stem Cell-Derived Extracellular Vesicles To Treat Intestinal Inflammation. | ACS Appl Mater Interfaces | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Attenuation of LPS-induced inflammatory responses in J774A.1 macrophages by phenylpropanoids and ursane triterpenes from Lavandula coronopifolia Poir. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A novel GntR-ABC efflux system mediates oxidative stress response, drug resistance, motility and virulence in Acinetobacter baumannii ATCC 17978. | Front Microbiol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Transdermal Delivery of an mRNA-Liposome Vaccine via Dissolving Microneedle to Preserve Vaccine Activity and Enhance Immune Activation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Neutralizing human monoclonal antibodies that target the PcrV component of the type III secretion system of Pseudomonas aeruginosa act through distinct mechanisms. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Combining antibody conjugates with cytotoxic and immune-stimulating payloads maximizes anti-cancer activity. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Ecto-5'-nucleotidase/CD73 reduces COX-2 expression in activated macrophages. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Optoacoustic-Guided Magnetic Microrobot Platform for Precision Drug Delivery. | Adv Mater | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Bacterial Extracellular Vesicles (BEVs) Derived From Lactococcus lactis as Multimodal Drug Delivery Platforms. | Int J Biomater | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Engineered extracellular vesicles demonstrate altered endocytosis and biodistribution and have superior oral siRNA delivery efficiency compared to lipid nanoparticles. | Int J Pharm X | 2025 | Its Methods give the RRID and name the line | PubMed | |
| A New Synthetic Analogue of Protectin DX With Enhanced Therapeutic Potential Against Metabolic-Associated Steatotic Liver Disease. | FASEB J | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Transposition of insertion sequence element from KPC plasmid enhances intracellular survival of Klebsiella pneumoniae. | EBioMedicine | 2025 | Its Methods give the RRID and name the line | PubMed | |
| TAK1 phosphorylation mediates macozinone (PBTZ169) induced innate immune activation against tuberculosis. | mSphere | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Sudapyridine (WX-081) inhibits Mycobacterium tuberculosis by targeting ATP synthase and upregulating host innate immunity. | mSphere | 2025 | Its Methods give the RRID and name the line | PubMed | |
| VAX014 Activates Tumor-Intrinsic STING and RIG-I to Promote the Development of Antitumor Immunity. | Mol Cancer Ther | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Macrophages are activated toward phagocytic lymphoma cell clearance by pentose phosphate pathway inhibition. | Cell Rep Med | 2024 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0358/papers